Friday, July 10, 2026

Intelligence · Clinical pipeline

Approved programs Pipeline Programs

ClinicalTrials.gov programs marked approved or launched in registry data.

Programs 1,839
Sponsors 1,771
Drugs 4,798

Quick answer

NovaPharmaNews tracks 1,839 approved programs pharmaceutical pipeline programs from ClinicalTrials.gov. ClinicalTrials.gov programs marked approved or launched in registry data.

Top sponsors

Pipeline programs

Page 3 of 39
  1. AO-128

    Takeda

    Impaired Glucose Tolerance (IGT)

    approved small molecule completed

    1 trial
  2. APHP 190183

    Pari Pharma GmbH

    Crohn’s disease

    approved small molecule active

    1 trial
  3. APHP180618

    Pari Pharma GmbH

    Asymptomatic Patients with frequent PVCs and normal LVEF

    approved small molecule active

    1 trial
  4. APHP200002

    Pari Pharma GmbH

    Patients with excessive supraventricular ectopies or short atrial runs (ESVEA) defined as ≥ 1% premature atrial contractions (PAC) /24 hours or any atrial runs ≥ 20 PACs (but shorter than 30 seconds) on a 24-hour Holter ECG monitoring and CHA2DS2VASC score ≥ 3. Patients with any atrial runs ≥ 20 PACs but shorter than 30 seconds on a 15-21 days Holter ECG monitoring and CHA2DS2VASC score ≥ 3 may also be included in the Short-Run trial.

    approved small molecule active

    1 trial
  5. APHP200020

    Pari Pharma GmbH

    Pyelonephritis, Kidney Transplant recipients

    approved small molecule active

    1 trial
  6. APHP210085

    Pari Pharma GmbH

    EA-COPD (with mechanical ventilation, invasive or non-invasive, or high-flow nasal oxygen therapy).

    approved small molecule active

    1 trial
  7. APHP220806

    Pari Pharma GmbH

    Women who delivered by caesarean and have a moderate postpartum iron deficiency anaemia defined by 8.0 g/dL ≤ postoperative Hb level ≤ 10.0 g/dL within 72h after delivery and a ferritinemia ≤ 100 ng/mL OR transferrin saturation ≤ 20% (Measured after postoperative Hb level measurement)

    approved small molecule active

    1 trial
  8. APOKYN

    SUPERNUS PHARMACEUTICALS, INC.

    Parkinson's Disease

    approved small molecule terminated

    2 trials
  9. ARALAST Alpha1-Proteinase Inhibitor

    Takeda

    Alpha1-antitrypsin Deficiency

    approved small molecule terminated

    1 trial
  10. ARALAST NP

    Takeda

    Chronic Obstructive Pulmonary Disease

    approved mab terminated

    1 trial
  11. ARIPIPRAZOLE , RISPERIDONE

    Disc Medicine

    Autism spectrum disorder

    approved small molecule active

    1 trial
  12. ARMYDA-AMULET

    Fondazione Telethon ETS

    Patients with atrial fibrillation undergoing percutaneous left atrial appendage closure with the Amulet device

    approved small molecule active

    1 trial
  13. ATORVASTATIN, PLACEBO

    Disc Medicine

    Atherosclerosis

    approved small molecule active

    1 trial
  14. ATRA+Arsenic

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Acute Promyelocytic Leukemia

    approved small molecule active

    1 trial
  15. AXS-05

    Axsome Therapeutics

    Major Depressive Disorder

    approved small molecule active

    3 trials
  16. AZD1222

    AstraZeneca

    COVID-19, SARS-CoV-2

    approved mab terminated

    1 trial
  17. Abemaciclib

    Eli Lilly and Company

    Metastatic Breast Cancer

    approved small molecule terminated

    1 trial
  18. Abemaciclib

    Eli Lilly and Company

    Breast Neoplasms

    approved small molecule completed

    1 trial
  19. Ablation

    Rhythm Pharmaceuticals Netherlands B.V.

    Atrial Fibrillation

    approved other terminated

    1 trial
  20. Academic Detailing

    United Therapeutics Europe Ltd

    Prostate Cancer

    approved other terminated

    1 trial
  21. Acarbose 100 MG

    RenJi Hospital

    PCOS

    approved small molecule active

    1 trial
  22. Access Arm

    Rhythm Pharmaceuticals Netherlands B.V.

    Heart Failure

    approved other completed

    1 trial
  23. Acetazolamide

    United Therapeutics Europe Ltd

    Hypobaric Hypoxia

    approved small molecule active

    1 trial
  24. Acetylsalicylzuur Aurobindo cardio for ST elevation myocardial infarct…

    Disc Medicine

    ST elevation myocardial infarction (STEMI)

    approved small molecule active

    1 trial
  25. Active Procedure

    United Therapeutics Europe Ltd

    Low Back Pain

    approved other completed

    1 trial
  26. Adalimumab

    Takeda

    Crohn's Disease

    approved small molecule active

    1 trial
  27. Adapalene 0.003 MG/MG / Benzoyl Peroxide 0.025 MG/MG Topical Gel [Epiduo]

    AVENUE THERAPEUTICS, INC.

    Acne Vulgaris

    approved small molecule completed

    1 trial
  28. Adderall

    BRIGHT MINDS BIOSCIENCES INC.

    Attention Deficit Disorder With Hyperactivity

    approved small molecule completed

    1 trial
  29. Adefovir

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Hepatitis B, Chronic

    approved small molecule completed

    1 trial
  30. AdreView

    Aspire Biopharma Holdings

    Heart Failure

    approved small molecule completed

    1 trial
  31. Adult group in immunogenicity and safety study of combined immunization

    Sinovac Research and Development Co.,

    COVID-19

    approved mab completed

    1 trial
  32. Advair Diskus100/50 µg

    Teva Pharma GmbH

    Asthma

    approved small molecule completed

    1 trial
  33. Aerosolized 13 cis retinoic acid plus Vitamin D

    The First People's Hospital of Lianyungang

    Post COVID-19 Anosmia (Loss of Smell)

    approved small molecule active

    1 trial
  34. Afatinib

    Boehringer Ingelheim

    Carcinoma, Non-Small-Cell Lung

    approved small molecule completed

    1 trial
  35. Aflibercept

    Regeneron UK Limited

    Fibrovascular Pigment Epithelial Detachment

    approved small molecule terminated

    1 trial
  36. Aflibercept

    Regeneron UK Limited

    Exudative Macular Degeneration

    approved small molecule completed

    1 trial
  37. Aflibercept

    Regeneron UK Limited

    Age Related Macular Degeneration

    approved small molecule active

    1 trial
  38. Aflibercept

    Regeneron UK Limited

    Diabetic Retinopathy

    approved small molecule completed

    2 trials
  39. Aflibercept

    Regeneron UK Limited

    Submacular Vascularized Pigment Epithelial Detachments

    approved small molecule completed

    1 trial
  40. Aflibercept

    Regeneron UK Limited

    Diabetic Macular Edema

    approved small molecule completed

    2 trials
  41. Aflibercept

    Regeneron UK Limited

    Retinal Vein Occlusion

    approved small molecule active

    2 trials
  42. Aflibercept (2.0 mg)

    Regeneron UK Limited

    Macular Edema With Central Retinal Vein Occlusions

    approved small molecule completed

    1 trial
  43. Aflibercept (BAY86-5321, Eylea)

    Regeneron UK Limited

    Diabetic Macular Edema

    approved small molecule completed

    1 trial
  44. Aflibercept 8 mg (VEGF Trap-Eye, BAY86-5321)

    Regeneron UK Limited

    Diabetic Macular Edema (DME)

    approved small molecule active

    1 trial
  45. Aflibercept Injection

    Regeneron UK Limited

    Diabetic Retinopathy

    approved small molecule completed

    2 trials
  46. Aflibercept Ophthalmic

    Regeneron UK Limited

    Wet Macular Degeneration

    approved small molecule completed

    1 trial
  47. AirDuo Digihaler

    Teva Pharma GmbH

    Asthma

    approved other completed

    1 trial
  48. Albendazole

    United Therapeutics Europe Ltd

    Ascariasis

    approved small molecule completed

    1 trial

Frequently asked questions

How many Approved programs pipeline programs are in the directory?

1,839 published programs match this development stage in our ClinicalTrials.gov index.

What defines this pipeline stage?

Phase and status reflect ClinicalTrials.gov registry fields at last sync. See our clinical trial phases reference for methodology.